FDA Inspection 853508 — Chongqing Carelife Pharmaceutical Co., Ltd.
The FDA completed an inspection of Chongqing Carelife Pharmaceutical Co., Ltd. on Oct 31, 2013 in Chongqing. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 31, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chongqing (China)